IFNAR1 and IFNAR2 polymorphisms confer susceptibility to multiple sclerosis but not to interferon-beta treatment response.
Leyva L, Fernández O, Fedetz M, Blanco E, Fernández VE, Oliver B, León A, Pinto-Medel MJ, Mayorga C, Guerrero M, Luque G, Alcina A, Matesanz F.
Leyva L, et al. Among authors: fedetz m.
J Neuroimmunol. 2005 Jun;163(1-2):165-71. doi: 10.1016/j.jneuroim.2005.02.010. Epub 2005 Apr 22.
J Neuroimmunol. 2005.
PMID: 15885318